Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Citrate anticoagulation during post-dilution hemodiafiltration with a high cut-off (Theralite) membrane.
Ther Apher Dial
June 2011
Department of Nephrology, University Medical Centre Ljubljana, Ljubljana, Slovenia.
Citrate anticoagulation has not yet been described for hemodiafiltration (HDF) with high cut-off (HCO) membranes, which can be used in the treatment of cast nephropathy secondary to multiple myeloma. A 57-year-old male patient with multiple myeloma and acute renal failure was treated with HDF using a HCO membrane (Theralite) each or every other day. Due to thrombocytopenia, citrate anticoagulation was done for the first 7 h, and anticoagulant-free HDF was performed for the last hour to avoid citrate accumulation.
View Article and Find Full Text PDFCitrate anticoagulation for postdilutional online hemodiafiltration with calcium-containing dialysate and infusate: significant clotting in the venous bubble trap.
Int J Artif Organs
April 2008
Department of Nephrology, Center for Dialysis, University Medical Center Ljubljana, Ljubljana, Slovenia.
Background: The aim of this prospective clinical study was to assess safety and antithrombotic efficacy of a regional citrate anticoagulation protocol for postdilutional online hemodiafiltration (HDF) with calcium-containing dialysate and infusate.
Methods: Nineteen postdilutional online HDF procedures with citrate anticoagulation were performed in 9 end-stage renal disease patients. Calcium-containing (1.
Dialysate/infusate calcium and magnesium.
Contrib Nephrol
December 2002
Nephrology and Dialysis Unit, Mauriziano Umberto I Hospital, Turin, Italy.
Dialysate/infusate composition and infusion mode in on-line hemodiafiltration.
Contrib Nephrol
December 2002
Nephrology and Dialysis Unit, Ospedale di Sondrio, Bergamo, Italy.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!